This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Gears Up for Q4 Earnings: Here's What You Should Understand
by Zacks Equity Research
MO's Q4 results are likely to reflect gains from pricing actions and strength in NJOY and on! amid shifting consumer preferences.
Sysco Set to Release Q2 Earnings: Should You Expect a Beat This Time?
by Zacks Equity Research
SYY's Q2 results are likely to reflect gains from Food-Away-From-Home sector along with improved efficiency and supply-chain productivity.
Procter & Gamble Stock Gains as Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
PG's Q2 results reflect robust organic sales rise, core EPS growth and strong cash returns to shareholders. It remains on track to reach its fiscal 2025 view.
EYE or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EYE vs. CLX: Which Stock Is the Better Value Option?
Why Clorox (CLX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
McCormick Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
MKC's Q4 results are likely to reflect improved volume trends, though high SG&A costs are likely to have dampened profits.
Procter & Gamble Stock: A Buy Opportunity Before Q2 Earnings?
by Rajani Lohia
PG's Q2 results should benefit from brand strength and solid strategies, offset by issues in Greater China, geopolitical tensions and currency volatility.
Buy 4 Consumer Staples Stocks to Navigate Market Volatility
by Ritujay Ghosh
Consumer staple stocks like CLX, MO, OLLI and TSN are a safe bet during times of market volatility.
Take the Zacks Approach to Beat the Markets: AppLovin, MasTec, Walmart in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Albertsons' Q3 Earnings Beat Estimates, Digital Sales Rise 23% Y/Y
by Zacks Equity Research
ACI's third-quarter fiscal 2024 results highlight strong year-over-year growth in digital sales, pharmacy operations and membership in its loyalty program.
Clorox Stock Rises 23% in Six Months: Is it Time to Buy or Avoid?
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Down -5.86% in 4 Weeks, Here's Why You Should You Buy the Dip in Clorox (CLX)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Clorox (CLX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
4 Consumer Product Stocks Gaining Attention Amid Industry Momentum
by Vrishali Bagree
The Zacks Consumer Products - Staples industry participants thrive on innovation and digital growth, catering to evolving consumer preferences. Solid saving efforts keep KMB, CLX, ACI and OLLI well-placed amid cost challenges.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
Why These 5 Consumer Staple Stocks are Perfect for Investing in 2025
by Rajani Lohia
The consumer goods industry is poised for a potential rebound in 2025, driven by falling inflation, rising real wages and accumulated savings.
ACI vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACI vs. CLX: Which Stock Is the Better Value Option?
Take the Zacks Approach to Beat the Markets: Talkspace, Agilysys, Axon Enterprise in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Fed Signals Fewer Rate Cuts in 2025: 4 Low-Beta Staples Stocks to Buy
by Ritujay Ghosh
Consumer staple stocks like TSN, UNFI, INGR and CLX that belong to the defensive space are a safe bet during times of market volatility.
Clorox Gains 20.5% in Past Six Months: Time to Buy or Hold the Stock?
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Carriage Services (CSV) have performed compared to their sector so far this year.
Newell Stock Hits 52-Week High: Is There More Room for Growth?
by Zacks Equity Research
NWL stock's momentum is backed by its emphasis on investing in innovation, brand-building, and go-to-market excellence for its most profitable brands and markets.
Clorox (CLX) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Clorox (CLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Is Grocery Outlet (GO) Up 22.2% Since Last Earnings Report?
by Zacks Equity Research
Grocery Outlet (GO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox's Pricing & Cost-Saving Efforts Bode Well: Apt to Hold the Stock
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.